At Biosfer Teslab, scientific innovation and translational research are the driving forces behind our commitment to more precise and personalized medicine. Throughout 2025, we have strengthened this commitment through the development of new R&D&I projects, the publication of high-impact scientific articles, participation in European initiatives, and active collaboration with the international scientific community.
This newsletter highlights the year’s key achievements, reflecting our ongoing efforts to translate scientific knowledge into solutions with real clinical impact. From advances in metabolomics, lipidomics, and multi-omics approaches to participation in international conferences and collaborative research projects, each milestone represents another step toward improving the diagnosis, prevention, and treatment of complex diseases.
We sincerely thank our collaborators, clients, and partners for their trust and continued support. Their contribution enables us to keep advancing our mission of generating knowledge, fostering innovation, and contributing to the progress of precision medicine.
